Year archive

H. Lundbeck A — 2024 filings

All 22 regulatory filings released by H. Lundbeck A (HLUN) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
Delisting Announcement 2024 Delisting Announcement	2024-11-28	English
Regulatory Filings 2024 Regulatory Filings	2024-10-31	English
Lundbeck announces positive results from phase III pivotal trial (SUNRISE) of Vyepti® (eptinezumab) in migraine prevention Regulatory Filings	2024-10-31	English
M&A Activity 2024 M&A Activity	2024-10-14	English
Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline M&A Activity	2024-10-14	Danish
Earnings Release 2024 Earnings Release H1 2024	2024-08-20	English
Lundbeck raised financial guidance following strong growth (+19% CER) from strategic brands, on path towards becoming a Focused Innovator Regulatory Filings	2024-08-20	Danish
Earnings Release 2024 Earnings Release H1 2024	2024-08-20	English
Lundbeck raises financial guidance for 2024 Earnings Release H1 2024	2024-08-20	Danish
Regulatory Filings 2024 Regulatory Filings	2024-06-25	English
Lundbeck and Otsuka announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD) Regulatory Filings	2024-06-25	Danish
Director's Dealing 2024 Director's Dealing	2024-02-16	English
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties Director's Dealing	2024-02-16	English
Director's Dealing 2024 Director's Dealing	2024-02-07	English
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties Director's Dealing	2024-02-07	English
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-02-07	English
Report Publication Announcement 2024 Report Publication Announcement	2024-02-07	English
Lundbeck Annual Report 2023 Annual Report FY 2023	2024-02-07	English
Earnings Release 2023 Earnings Release FY 2023	2024-02-07	English
Lundbeck reached record revenue of DKK 20 billion in 2023 with strong growth momentum set to continue in 2024 Earnings Release FY 2023	2024-02-07	English
Earnings Release 2024 Earnings Release Q1 2024	2024-01-31	English
Lundbeck announces supportive phase II results with Lu AF82422 in the treatment of Multiple System Atrophy from the AMULET trial Regulatory Filings	2024-01-31	English

Filings by year

2026 17 filings
2025 28 filings
2024 22 filings
2023 28 filings
2022 27 filings
2021 20 filings
2020 14 filings
2019 55 filings
2018 63 filings
2017 105 filings
2016 122 filings
2015 31 filings
2014 43 filings
2013 56 filings
2012 66 filings
2011 73 filings
2010 74 filings
2009 42 filings
2008 29 filings
2007 32 filings